Hsbc Holdings PLC Gilead Sciences, Inc. Call Options Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $3.79 Million - $4.37 Million	-60,000 Reduced 31.63%	129,700 $8.9 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $7.92 Million - $9.66 Million	110,700 Added 140.13%	189,700 $13.9 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $6.02 Million - $6.82 Million	-82,100 Reduced 50.96%	79,000 $6.4 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $4.72 Million - $5.15 Million	63,800 Added 65.57%	161,100 $12.1 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $15.7 Million - $17.9 Million	-206,300 Reduced 67.95%	97,300 $7.5 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $25.5 Million - $29.1 Million	-329,900 Reduced 52.08%	303,600 $25.2 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $20.8 Million - $29.8 Million	333,300 Added 111.03%	633,500 $54.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $9.37 Million - $10.7 Million	157,400 Added 110.22%	300,200 $18.7 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $9.24 Million - $10.4 Million	-160,000 Reduced 52.84%	142,800 $8.89 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $5.27 Million - $6.6 Million	-91,000 Reduced 23.11%	302,800 $18 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $16.2 Million - $18.4 Million	250,100 Added 174.04%	393,800 $28.6 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $3.93 Million - $4.24 Million	58,000 Added 67.68%	143,700 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $2.77 Million - $3.03 Million	43,700 Added 104.05%	85,700 $5.9 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.09 Million - $3.53 Million	-51,500 Reduced 55.08%	42,000 $2.71 Million
Q4 2020 Feb 25, 2021	BUY	$56.65 - $64.55 $254,925 - $290,475	4,500 Added 5.06%	93,500 $5.45 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $428,490 - $538,752	-6,900 Reduced 7.19%	89,000 $5.62 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $1.61 Million - $1.86 Million	22,200 Added 30.12%	95,900 $7.38 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $9.03 Million - $11.6 Million	-144,200 Reduced 66.18%	73,700 $5.51 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $6.32 Million - $6.95 Million	-102,500 Reduced 31.99%	217,900 $14.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $4.73 Million - $5.22 Million	75,700 Added 30.94%	320,400 $20.3 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $290,789 - $326,086	4,700 Added 1.96%	244,700 $16.5 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $14.2 Million - $15.9 Million	-226,900 Reduced 48.6%	240,000 $15.6 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $6.25 Million - $8.15 Million	103,200 Added 28.38%	466,900 $29.2 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $6.64 Million - $7.35 Million	93,100 Added 34.41%	363,700 $28.1 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $11.8 Million - $13.8 Million	-182,000 Reduced 40.21%	270,600 $19.2 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $20.9 Million - $25.5 Million	286,600 Added 172.65%	452,600 $34 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $30.4 Million - $35.7 Million	-427,400 Reduced 72.03%	166,000 $11.9 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $12.6 Million - $15 Million	-175,300 Reduced 22.8%	593,400 $48.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	768,700	768,700 $54.4 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.66 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.39 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.07 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.97 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account